NCT00954174
Clinical Trial Information
Trial Number: NCT00954174 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Female - Miscellaneous
- Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
- Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus, Fallopian Tube, Peritoneum or Ovary
Study ID:
GOG-0261
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00954174-D2 | This dataset contains quality of life (QOL) data from trial NCT00954174 presented in 35007153. NCT00954174-D1 contains patient characteristics, outcome data, and adverse event data. |
| NCT00954174-D1 | This dataset contains the data for the treatment comparison between Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in trial NCT00954174. NCT00954174-D2 contains quality-of-life data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®